-
Diagnostics World Brief | Brigham and Women’s Hospital announced this morning the launch of the Matchmaker Exchange, a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can “match” with a patient’s rare disease.
Sep 24, 2015
-
Massachusetts General Hospital |
MGH researchers have developed a device that can turns a smartphone camera into a microscope to diagnosis cancer and, in the process, reduce patients' anxiety and improve access to care. The next step is a clinical trial in Africa.
Sep 17, 2015
-
Stanford |
Today NIH launches its Undiagnosed Disease Network under the guidance of heart specialist Euan Ashley. Ashley sat for a Q&A with his home institution's news group.
Sep 16, 2015
-
Diagnostics World Brief | Memorial Sloan Kettering Cancer Center and Illumina this morning announced a collaboration to conduct research studies that are critical to understanding the biology of circulating tumor DNA (ctDNA). The studies aim to inform the development of new strategies to diagnose and monitor cancer and to help establish ctDNA as an important marker in the study and eventual treatment of cancer.
Sep 16, 2015
-
Diagnostics World Brief | Less than a year after NextCODE Health was bought by Chinese services group WuXi PharmaTech, WuXi NextCODE has announced a partnership with the Children’s Hospital of Fudan University (CHFU) to bring genomic testing to clinical use in China for the first time.
Sep 16, 2015
-
Diagnostics World Brief Foundation Medicine today announced the launch of its precision medicine partner program, Precision Medicine Exchange Consortium (PMEC), to facilitate data exchange, advance research, and support education and applications of precision medicine in oncology and molecular pathology.
Sep 15, 2015
-
National Human Genome Research Institute |
In a new analysis, a working group of the Clinical Sequencing Exploratory Research (CSER) Consortium has offered an ethical framework to guide pediatricians in pursuing clinical sequencing studies, interpreting results, and, especially, disclosing findings. The study was posted online today.
Sep 14, 2015
-
Diagnostics World Brief | This morning, Pathway Genomics of San Diego announced the launch of two liquid biopsy tests to detect cancer-related DNA mutations, including one that the company claims is the first liquid biopsy on the market for early detection of cancer in healthy patients.
Sep 9, 2015
-
Diagnostics World | In a large pilot initiative with little precedent, HudsonAlpha and its genetic testing spinoff Kailos plan to offer free or steeply discounted genetic screens for susceptibility to breast cancer to thousands of women in the area of Huntsville, Alabama, including women with no known risk factors for the disease.
Sep 9, 2015
-
National Geographic Phenomena |
The Longitude Prize, brought to American shores at an event in Boston last night, is promising over $12 million for the first individual or organization to create a 30-minute, point-of-care diagnostic to detect antibiotic resistance across multiple species and strains of disease-causing bacteria.
Sep 9, 2015
-
WIRED |
The St. Louis company has pulled up roots and moved to San Francisco to join the Y Combinator tech accelerator, on a hunch that catching circular RNA could make for a multi-purpose diagnostic further upstream than traditional protein- and antibody-based tests.
Sep 8, 2015
-
MedPage Today | Authors of a new paper in JAMA Oncology argue that universal testing for breast cancer-related BRCA mutations offers vanishingly low benefit for the cost — but with several providers finding ways to offer these tests for just a few hundred dollars, that calculation may quickly be due for a revision.
Sep 4, 2015
-
MIT Technology Review | Doctors and genetic counselors question the need for blood tests during pregnancy that are expanding from conditions like Down syndrome to extremely rare and poorly understood microdeletions.
Sep 1, 2015
-
Boston Business Journal |
A new Cambridge diagnostic-maker with a test aimed at identifying genetic markers of cancer is taking a different tack from Foundation Medicine in hopes of an easier path to getting insurance reimbursement.
Aug 28, 2015
-
MIT Technology Review |
Quanterix and Banyan Biomarkers both say they've identified proteins that could lead to a blood test to quickly diagnose concussions. The proteins seem to increase in blood corresponding with the severity of brain injury. Banyan is in the midst of a clinical trial now.
Aug 28, 2015
-
New Scientist | As academics and commercial companies design machine learning programs to diagnose disease based on analysis of medical images, doctors and patients may have to learn to trust "black boxes" that can give medical answers but can't explain their reasoning.
Aug 26, 2015
-
Diagnostics World | The idea is beautiful: read the text of DNA and understand the workings of the body. Brendan Frey isn’t claiming it’s simple, but with advanced machine learning and expertise in cell and genome biology, Deep Genomics is chasing the vision. And the first application will be the clinical genetic testing market.
Aug 24, 2015
-
Diagnostics World | Now you can get genomics test results with an easy in-app purchase. Pathway Genomics is offering its Pathway Fit genetic test for purchase through the Pathway app, further lowering the barrier to test access.
Aug 21, 2015
-
Diagnostics World | As the FDA moves forward with its plan to regulate laboratory developed tests, Roger Klein, Chair of the Association for Molecular Pathology's Professional Relations Committee, tells Diagnostics World about his organization's alternative plan to modernize the way these tests are regulated while keeping their oversight under the current CLIA program.
Aug 20, 2015
-
AJMC | Myriad Genetics' new CEO, Mark Capone, is shifting the company's futures in molecular diagnostics, and competing with a broad new field of companies like Color Genomics and more.
Aug 14, 2015